What is the role of the cardiologist in future management of stroke prevention in atrial fibrillation?

Advances in Therapy

Volumn 28, Issue 1, 2011, Pages 1-12

  Velu, Selvakumar ^a   Lip, Gregory Y H ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

anticoagulants; atrial fibrillation; cardiologist; risk stratification; stroke; thromboprophylaxis

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; APIXABAN; BLOOD CLOTTING FACTOR 10A INHIBITOR; DABIGATRAN; DABIGATRAN ETEXILATE; ENDOXABAN; HEPARIN; RIVAROXABAN; UNCLASSIFIED DRUG; WARFARIN;

ANTICOAGULANT THERAPY; BLEEDING DISORDER; BRAIN HEMORRHAGE; CARDIOLOGIST; CARDIOVASCULAR RISK; CARDIOVERSION; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; DRUG COST; HEALTH CARE COST; HEALTH CARE SYSTEM; HEART ATRIUM FIBRILLATION; HOSPITAL COST; HUMAN; INCIDENCE; PATIENT CARE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PREVALENCE; REVIEW; STROKE PATIENT; SURGICAL RISK; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; VENOUS THROMBOEMBOLISM;

ALGORITHMS; ATRIAL FIBRILLATION; CARDIOLOGY; GREAT BRITAIN; HUMANS; PHYSICIAN'S ROLE; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; STROKE; THROMBOLYTIC THERAPY;

EID: 79952535377     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12325-010-0091-9     Document Type: Review

References (58)

1. C. Marini F. De Santis S. Sacco, et al. 2005 Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population based study Stroke 36 1115 1119 10.1161/01.STR.0000166053.83476.4a 15879330 (Pubitemid 40803473)
2. E.J. Benjamin D. Levy S.M. Vaziri R.B. D'Agostino A.J. Belanger P.A. Wolf 1994 Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study JAMA 271 840 844 1:STN:280: DyaK2c7lvVSksg%3D%3D 10.1001/jama.271.11.840 8114238 (Pubitemid 24076851)
3. A.S. Go E.M. Hylek K.A. Phillips, et al. 2001 Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study JAMA 285 2370 2375 1:STN:280:DC%2BD3M3ntleitQ%3D%3D 10.1001/jama.285.18.2370 11343485 (Pubitemid 32424106)
4. Y. Miyasaka M.E. Barnes B.J. Gersh, et al. 2006 Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence Circulation 114 119 125 10.1161/CIRCULATIONAHA.105.595140 16818816 (Pubitemid 44420743)
5. S. DeWilde I.M. Carey C. Emmas N. Richards D.G. Cook 2006 Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care Heart 92 1064 1107 1:STN:280:DC%2BD28vitFKntw%3D%3D 10.1136/hrt.2005.069492 16387813 (Pubitemid 44131331)
6. N.F. Murphy C.R. Simpson P.S. Jhund, et al. 2007 A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland Heart 93 606 612 10.1136/hrt.2006.107573 17277353 (Pubitemid 46722325)
7. G.Y. Lip D.J. Golding M. Nazir D.G. Beevers D.L. Child R.I. Fletcher 1997 A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project Br J Gen Pract 47 285 289 1:STN:280:DyaK2szmt12ltA%3D%3D 9219403 (Pubitemid 27208108)
8. J. Heeringa D.A. van der Kuip A. Hofman, et al. 2006 Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study Eur Heart J 27 949 945 10.1093/eurheartj/ehi825 16527828
9. I. Savelieva A.J. Camm 2000 Silent atrial fibrillation-another Pandora's box Pacing Clin Electrophysiol 23 145 148 1:STN:280:DC%2BD3c7ntl2qtQ%3D%3D 10.1111/j.1540-8159.2000.tb00794.x 10709221 (Pubitemid 30108462)
10. C.D. Furberg B.M. Psaty T.A. Manolio J.M. Gardin V.E. Smith P.M. Rautaharju 1994 Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health study) Am J Cardiol 74 236 241 1:STN:280: DyaK2czhtFaiuw%3D%3D 10.1016/0002-9149(94)90363-8 8037127 (Pubitemid 24239044)
11. J.L. Blackshear S.L. Kopecky S.C. Litin R.E. Safford S.C. Hammill 1996 Management of atrial fibrillation in adults: prevention of thromboembolism and symptomatic treatment Mayo Clin Proc 71 150 160 1:CAS:528:DyaK28Xhs1Snsr4%3D 10.4065/71.2.150 8577189
12. S. Stewart N.F. Murphy A. Walker A. McGuire J.J. McMurray 2004 Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK Heart 90 286 292 1:STN:280:DC%2BD2c%2FnsleisA%3D%3D 10.1136/hrt.2002.008748 14966048 (Pubitemid 38250721)
13. A. Majeed K. Moser K. Carroll 2001 Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database Heart 86 284 288 1:STN:280:DC%2BD3MvmvFCjsA%3D%3D 10.1136/heart.86.3.284 11514479 (Pubitemid 32800076)
14. S. Stewart N. Murphy A. Walker A. McGuire J.J. McMurray 2004 Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK Heart 90 286 292 1:STN:280:DC%2BD2c%2FnsleisA%3D%3D 10.1136/hrt.2002.008748 14966048 (Pubitemid 38250721)
15. W.A. Wattigney G.A. Mensah J.B. Croft 2003 Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention Circulation 108 711 716 10.1161/01.CIR.0000083722.42033.0A 12885749 (Pubitemid 36999256)
16. J.Y. Le Heuzey O. Paziaud O. Piot, et al. 2004 Cost of care distribution in atrial fibrillation patients: the COCAF study Am Heart J 147 121 126 10.1016/S0002-8703(03)00524-6 14691429 (Pubitemid 38037407)
17. G.Y. Lip K.N. Tean F.G. Dunn 1994 Treatment of atrial fibrillation in a district general hospital Br Heart J 71 92 95 1:STN:280:DyaK2c7ivVGjsg%3D%3D 10.1136/hrt.71.1.92 8297706 (Pubitemid 24061020)
18. J. Zarifis G. Beevers G.Y. Lip 1997 Acute admissions with atrial fibrillation in a British multiracial hospital population Br J Clin Pract 51 91 96 1:STN:280:DyaK2szgtFyqsw%3D%3D 9158252
19. A. Ringborg R. Nieuwlaat P. Lindgren, et al. 2008 Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation Europace 10 403 411 10.1093/europace/eun048 18326853 (Pubitemid 351767678)
20. P.A. Wolf T.R. Dawber H.E. Thomas Jr W.B. Kannel 1978 Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study Neurology 28 973 977 1:STN:280:DyaE1M7jsFGgtQ%3D%3D 570666 (Pubitemid 8401525)
21. P. Wolf R. D'Agostino A. Belanger W. Kannel 1991 Probability of stroke: a risk profile from the Framingham study Stroke 22 312 318 1:STN:280: DyaK3M7msFWgtA%3D%3D 2003301
22. L.A. Pearce R.G. Hart J.L. Halperin 2000 Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation Am J Med 109 45 51 1:STN:280:DC%2BD3cvjtFyrsw%3D%3D 10.1016/S0002-9343(00)00440-X 10936477 (Pubitemid 30608736)
23. B.F. Gage A.D. Waterman W. Shannon M. Boechler M.W. Rich M.J. Radford 2001 Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2864 2870 1:STN:280:DC%2BD3MzntFKgsQ%3D%3D 10.1001/jama.285.22.2864 11401607 (Pubitemid 32537350)
24. S.L. Kopecky B.J. Gersh M.D. McGoon, et al. 1999 Lone atrial fibrillation in elderly persons: a marker for cardiovascular risk Arch Intern Med 159 1118 1122 1:STN:280:DyaK1M3ms1Ohsw%3D%3D 10.1001/archinte.159.10.1118 10335690 (Pubitemid 29230865)
25. Atrial Fibrillation Investigators. 1994 Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation Arch Intern Med 154 1449 1457 10.1001/archinte.154.13.1449 (Pubitemid 24208570)
26. Stroke Prevention Atrial Fibrillation III Writing Committee. 1998 Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study JAMA 279 1273 1277 10.1001/jama.279.16.1273 (Pubitemid 28180779)
27. Stroke Prevention in Atrial Fibrillation Investigators. 1992 Predictors of thromboembolism in atrial fibrillation, I: clinical features of patients at risk Ann Intern Med 116 1 5
28. J.C. van Latum P.J. Koudstaal G.S. Venables J. van Gijn L. J. Kappelle A. Algra 1995 Predictors of major vascular events in patients with a transient ischemic attack or minor ischemic stroke and with nonrheumatic atrial fibrillation Stroke 26 801 806 7740570
29. P. Sandercock J. Bamford M. Dennis, et al. 1992 Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project) BMJ 305 1460 1465 1:STN:280:DyaK3s7ltlamtQ%3D%3D 10.1136/bmj.305.6867.1460 1493391
30. H.S. Jorgensen H. Nakayama J. Reith H.O. Raaschou T.S. Olsen 1996 Acute stroke with atrial fibrillation The Copenhagen Stroke Study. Stroke 27 1765 1769 1:STN:280:DyaK28vjvV2qsw%3D%3D
31. D.A. Fitzmaurice F.D. Hobbs S. Jowett, et al. 2007 Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial BMJ 335 383 10.1136/bmj.39280.660567. 55 17673732 (Pubitemid 47359316)
32. T. Watson E. Shantsila G.Y. Lip 2009 Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited Lancet 10 373
33. E. Williams M. Ansari G. Lip 2001 Managing atrial fibrillation in the accident and emergency department Quart J Med 94 609 614 1:STN:280: DC%2BD3Mnlt1Omuw%3D%3D (Pubitemid 33100209)
34. M.C. Fang A.S. Go Y. Chang 2008 Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation J Am Coll Cardiol 51 810 815 10.1016/j.jacc.2007.09.065 18294564 (Pubitemid 351253746)
35. G. Lip R. Nieuwlaat R. Pisters D.A. Lane H.J. Crijns 2010 Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor based approach: the Euro Heart Survey on Atrial Fibrillation Chest 137 263 272 10.1378/chest.09-1584 19762550
36. European Heart Rhythm Association European Association for Cardio-Thoracic Surgery A.J. Camm, et al. 2010 Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Europace 12 1360 1420 10.1093/europace/euq160 20876603
37. P. Cantley B. McKinstry D. Macaulay J. McMillan J.B. Irving 1999 Atrial fibrillation in general practice: how useful is echocardiography in selection of suitable patients for anticoagulation? Br J Gen Pract 49 219 220 1:STN:280:DyaK1M3nsVyqtA%3D%3D 10343428 (Pubitemid 29119099)
38. G.C. Flaker K.A. Fletcher R.M. Rothbart J.L. Halperin R.G. Hart 1995 Clinical and echocardiographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation Am J Cardiol 76 355 358 1:STN:280:DyaK2Mzms1ersQ%3D%3D 10.1016/S0002-9149(99)80100-3 7639159
39. A.L. Klein R.D. Murray R.A. Grimm 2001 Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation J Am Coll Cardiol 37 691 704 1:STN:280:DC%2BD3Mnjslahuw%3D%3D 10.1016/S0735-1097(00) 01178-5 11693739 (Pubitemid 32202432)
40. G.Y. Lip J. Zarifis R.D. Watson D.G. Beevers 1996 Physician variation in the management of patients with atrial fibrillation Heart (British Cardiac Society) 75 200 205 1:STN:280:DyaK283ks1yqsA%3D%3D 10.1136/hrt.75.2.200 (Pubitemid 26068699)
41. A.L. Klein R.A. Grimm R.D. Murray, et al. 2001 Assessment of Cardioversion Using Transesophageal Echocardiography Investigators. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation N Engl J Med 344 1411 1420 1:STN:280:DC%2BD3M3ms1eitg%3D%3D 10.1056/NEJM200105103441901 11346805 (Pubitemid 32402097)
42. D.A. Fitzmaurice 2007 The NICE guidelines on atrial fibrillation: a personal view Br J Cardiol 14 29 30 (Pubitemid 46380962)
43. S. de Denus C.A. Sanoski J. Carlsson G. Opolski S.A. Spinler 2005 Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis Arch Intern Med 165 258 262 10.1001/archinte.165.3.258 15710787 (Pubitemid 40216276)
44. D. Roy M. Talajic S. Nattel, et al. 2008 Atrial Fibrillation and Congestive Heart Failure Investigators. Rhythm control versus rate control for atrial fibrillation and heart failure N Engl J Med 358 2667 2677 1:CAS:528:DC%2BD1cXns1Wrtr0%3D 10.1056/NEJMoa0708789 18565859 (Pubitemid 351860859)
45. C. Heneghan P. Alonso-Coello J.M. Garcia-Alamino R. Perera E. Meats P. Glasziou 2006 Self-monitoring of oral anticoagulation: a systematic review and metaanalysis Lancet 367 404 411 1:STN:280:DC%2BD28%2FntlSguw%3D%3D 10.1016/S0140-6736(06)68139-7 16458764 (Pubitemid 43184260)
46. J.M. Garcia-Alamino A.M. Ward P. Alonso-Coello, et al. 2010 Self-monitoring and self-management of oral anticoagulation Cochrane Database Syst Rev 4 CD003839 20393937
47. D.B. Matchar A. Jacobbson R. Dolor, et al. 2010 THINRS investigators. Effect of home testing of international normalized ratio on clinical events N Engl J Med 363 1608 1620 1:CAS:528:DC%2BC3cXhtlCqurbI 10.1056/NEJMoa1002617 20961244
48. S.J. Connolly M.D. Ezekowitz S. Yusuf, et al. 2009 RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 1139 1151 1:CAS:528:DC%2BD1MXhtFOjsLnN 10.1056/NEJMoa0905561 19717844
49. K.M. Koti A. Parekh S.J. Connolly, et al. 2010 Dabigatran versus warfarin in patients with atrial fibrillation - an analysis of patients undergoing cardioversion J Am Coll Cardiol 55 A4.E40 10.1016/S0735-1097(10)60041-1
50. Connolly S, Eikelboom J, Flaker G, et al. AVERROES: apixaban versus acetyl salicyclic acid to prevent strokes. Presented at: European Society of Cardiology; August 31, 2010; Stockholm, Sweden.
51. W.D. Johnson A.K. Ganjoo C.D. Stone R.C. Srivyas M. Howard 2000 The left atrial appendage: our most lethal human attachment! Surgical implications Eur J Cardiothorac Surg 17 718 722 1:STN:280:DC%2BD3cvgvV2nsQ%3D%3D 10.1016/S1010-7940(00)00419-X 10856866 (Pubitemid 30364952)
52. J.S. Healy E. Crystal A. Lamy, et al. 2005 Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary artery bypass surgery in patients at risk for stroke Am Heart J 150 288 293 10.1016/j.ahj.2004.09.054 (Pubitemid 41116255)
53. M.A. Garcia-Fernandez E. Perez-David J. Qulies, et al. 2003 Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study J Am Coll Cardiol 42 1253 1258 10.1016/S0735-1097(03)00954-9 14522491 (Pubitemid 37188352)
54. R.O. Bonow B. Carabello K. Chatterjee, et al. 2006 Guidelines for the management of patients with valvular heart disease: executive summary A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 114 e84 231
55. P.C. Block S. Burstein P.N. Casale, et al. 2009 Percutaneous left atrial appendage occlusion in atrial fibrillation suboptimal for warfarin therapy. 5-year results of PLAATO study JACC Cardiovasc Interv 2 594 600 10.1016/j.jcin.2009.05.005 19628179
56. D.R. Holmes V.Y. Reddy Z.G. Turi, et al. 2009 PROTECT AF Investigators Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomized non-inferiority trial. Lancet 374 534 542 1:CAS:528:DC%2BD1MXpvFyguro%3D
57. M. Hughes G.Y. Lip 2007 Risk factors for anticoagulation related bleeding complications in patients with atrial fibrillation: a systematic review Q J Med 100 599 607 1:STN:280:DC%2BD2srpvVeksA%3D%3D (Pubitemid 47543414)
58. R. Pisters D.A. Lane R. Nieuwlaat C.B. de Vos H.J. Crijns G.Y. Lip 2010 A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: the Euro Heart Survey Chest 138 1093 1100 10.1378/chest.10-0134 20299623